Back to search
FDAFDA · Food and drugs·Recall number D-0626-2025

Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension Rx Only, For Use in Ears Only, Manufactured By: Novartis Manufacturing NV, Belgium, Distributed by: Sandoz, Inc., Princeton, NJ, NDC# 0781-6186-67, Carton NDC# 0781-6186-67

Published September 17, 2025 · Recall initiated: August 13, 2025

Summary

FDA records drug Class II recall D-0626-2025, published September 17, 2025 and initiated August 13, 2025. Recalling firm: Sandoz Inc; Status: Ongoing; Reported quantity: 1,680 bottles; Lot: Lot # VNF35A, Exp.08/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Temperature Abuse

What to do

Voluntary: Firm initiated · Letter

Get an email if CIPROFLOXACIN AND DEXAMETHASONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CIPROFLOXACIN AND DEXAMETHASONE
Manufacturer
Sandoz Inc
Distributor
Product was distributed to one consignee in CA.
UPC
0307816186677
Lot
Lot # VNF35A, Exp.08/31/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension Rx Only, For Use in Ears Only, Manufactured By: Novartis Manufacturing NV, Belgium, Distributed by: Sandoz, Inc., Princeton, NJ, NDC# 0781-6186-67, Carton NDC# 0781-6186-67 recalled?

Yes. FDA published recall D-0626-2025 on September 17, 2025. Reported hazard: Temperature Abuse

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CIPROFLOXACIN AND DEXAMETHASONE. UPC: 0307816186677.